Article
The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies.
BMC cancer - 22 Oct 2010
Tang Kefu, Li Yang, Zhang Zhao, Gu Yunmin, Xiong Yuyu, Feng Guoyin, He Lin, Qin Shengying
Abstract excerpt
BACKGROUND: CYP2E1 encodes a member of the cytochrome P450 superfamily of enzymes which play a central role in activating and detoxifying many carcinogens and endogenous compounds thought to be involved in the development of cancer. The PstI/RsaI and DraI polymorphism are two of the most commonly studied polymorphisms of the gene for their association with risk of head and neck cancer, but the results are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.